Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.0K
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epstein-Barr Virus-host epigenetic interplay: mechanisms of regulation and therapeutic potential.

Clinical epigenetics·2026
Same author

Immune surveillance interrupted: how cancer exploits trogocytosis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Using blood cell histogram analysis for swift anemia diagnosis alongside complete blood cell count and peripheral blood film.

Laboratory medicine·2026
Same author

Clinical presentation domains and venous anatomical patterns in cerebral venous thrombosis: a retrospective cohort study.

BMC neurology·2026
Same author

Molecular and Serological Evaluation of Hantavirus in Wild Rodents in Kohgiluyeh and Boyer-Ahmad Province, Southwest of Iran.

Journal of arthropod-borne diseases·2026
Same author

IL-21 rs2055979 and serum IL-21 levels are associated with both non-segmental and segmental vitiligo in an Iranian cohort.

BMC immunology·2026

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

EBV viral load and miR-BART10-3p expression in multiple sclerosis: A case-control study.

Sanaz Baghban Rahimi1, Seyed Mohammad Ali Hashemi1, Maryam Poursadeghfard2

  • 1Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Multiple Sclerosis and Related Disorders
|May 1, 2026
PubMed
Summary

Epstein-Barr virus (EBV) load and miR-BART10-3p expression are elevated in newly diagnosed multiple sclerosis (MS) patients, suggesting a role in MS pathogenesis. These markers may help monitor EBV activity and disease progression.

Keywords:
EBNA1Epstein-barr virusMultiple sclerosisViral LoadmiR-BART10–3p

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.1K

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.1K

Area of Science:

  • Virology
  • Immunology
  • Neuroscience

Background:

  • Epstein-Barr virus (EBV) is linked to multiple sclerosis (MS), but mechanisms remain unclear.
  • This study investigates EBV viral load and miR-BART10-3p in MS patients from Southern Iran.

Purpose of the Study:

  • To determine the association between EBV viral load and EBV-encoded miR-BART10-3p expression with MS.
  • To explore potential molecular mechanisms linking EBV to MS pathogenesis.

Main Methods:

  • Case-control study with 110 participants (40 newly diagnosed MS, 20 MS-IFN, 20 MS-mAb, 30 healthy controls).
  • Quantification of EBV viral load and miR-BART10-3p expression using qPCR and q-RT-PCR.
  • EBV viral capsid antigen (VCA) IgG serostatus determined by ELISA.

Main Results:

  • Significantly elevated EBV viral load in newly diagnosed MS (ND-MS) and interferon-β treated MS (MS-IFN) groups compared to controls.
  • Significantly higher miR-BART10-3p expression in ND-MS and MS-IFN groups, but lower in B-cell-depleting therapy MS (MS-mAb) group.
  • No significant differences in EBV-VCA IgG seropositivity or associations with age/sex.

Conclusions:

  • EBV viral load and miR-BART10-3p expression may play a role in MS pathogenesis.
  • These markers could serve as indicators for monitoring EBV activity and MS progression.
  • Further research is needed to validate findings and assess clinical utility.